JOB POSTING: CRA at BC Children’s (Research Tech III)

UBC Department of Pediatrics and the Childhood Cancer & Blood Research Group (CCBR) is looking for a Clinical Research Associate (Tech 3) to join our team. As a part of BC Children’s Hospital Division of Hematology/Oncology/Bone Marrow Transplant (Hem/Onc/BMT) and Research Institute, the CCBR program supports around 100 active clinical research studies for children in British Columbia with cancer and blood disorders.  These studies include, but are not limited to, research on active treatment, supportive care, and the long-term effects of cancer and blood disorders therapy.

The job posting is available here: www.staffcareers.ubc.ca/28431.  It will be posted for applications through end of day Dec 24th, 2017.  Only shortlisted candidates will be contacted.

Advertisements

Get CME credits for keeping up on your journal reading – BESTBITS.ca is an accredited online Peds hem/onc journal club. See post for link to sample issue

BestBits.ca Pediatric Hematology Oncology Journal Review and Virtual Journal Club

BestBits.ca Journal Review is a synopsis of current literature in Pediatric Hematology & Oncology.  BestBits Pediatric Hematology Oncology Virtual Journal Club discusses featured articles from each of the Journal Review issues. The aim is to create an open access online interactive learning resource of relevant current literature for Pediatric Hematology/ Oncology health professionals and facilitate practice of journal screening, reading, summarizing and critical appraisal.

The August/September edition of BestBits.ca is now available online and as a free PDF download.

Virtual Journal Club: Featured articles are discussed in our Online Journal Club.

CME credits for both tracking journal reading and participation in journal club

REMINDER: LOI for the C17 Research Network Operating and The 100% Fund C17 Grant (infant ALL, rhabdomyosarcoma, Ewing sarcoma) competitions are due 14-Dec-2017 at 4pm MT

C17 announced on Oct-24 the inaugural round of The 100% Fund C17 Grant Competition and Round 21 of the C17 Research Network Operating Grant Competition.

The C17 Operating Grant Competition is focused on multicenter, multidisciplinary pediatric oncology/hematology research.

The purpose of The 100% Fund Grant Competition is to target directly pediatric cancers that are rare and hard to treat—cancers that have not responded to available therapies. Applications addressing the cancer types below will be considered for the fall 2017 competition.

In recognition of its 30th anniversary, Childhood Cancer Canadaestablished The 100% Fund to challenge the odds for children and teens who do not, yet, have their cure.

Please see the calls for LOI, LOI forms and C17 Award Guide linked below. The application form and guidance document also can be downloaded from the C17 website (www.c17.ca/council-and-administrators/research/) under Committees> Research Network. The submission deadline for C17 LOIs is December 14, 2017 at 4 PM MST.

Congratulations to Sumit Gupta (Sick Kids), Anthony Chan (McMaster) and Livia Garzia (McGill) on their newly awarded C17 and Ewing sarcoma research grants

The C17 Research Network announces the funding of the following 3 grants.

Livia Garzia, McGill University (Ewing sarcoma competition) was awarded $99,894 for her grant entitled “Functional genomics of metastatic Ewing sarcoma”

Sumit Gupta, The Hospital for Sick Children, was awarded $120,000 for his grant entitled “Healthcare utilization and costs associated with current and future treatment strategies for childhood acute lymphoblastic leukemia: Building a policy model for clinicians and funders”

Anthony Chan, McMaster University, was awarded $118,763 for his grant entitled “Understanding involvement in obstetric and neonatal decision making: a qualitative study to explore the experience, preferences and needs of parents of infants at risk or affected by moderate or severe hemophilia A or B”

 

 

 

AYA-targeted YouTube resource outlining oocyte preservation https://youtu.be/wB9lfKlYReY

Please see the link below for a white board style video that outlines the process of egg/oocyte preservation for young women considering this method of fertility preservation. Targeted to AYA patients (15+).

https://youtu.be/wB9lfKlYReY

Call for C17 Guidelines Committee Co-chair

The C17 Guidelines Committee is a national multidisciplinary committee of pediatric hematology/oncology health care professionals which was originally  established to develop, disseminate and evaluate evidence-based clinical practice guidelines. Over time the focus has become more directed on the endorsement of existing published guidelines for oncology patients and more recently the Committee has expanded the focus to include clinical indicators for non-malignant hematology.

We would like to recruit a co-chair that is able to dedicate time to re-establishing a work flow and budget for the committee to enable a viable process for ongoing guideline endorsement for oncology and non-malignant hematology patients in Canada.  Ideally the candidate would be a Physician.

Send applications to Kathy in the C17 office:  Katherine.Brodeur-Rob at AHS.ca

 

 

JAN 5 2018: Deadline Extended – TCPS 2 Consultation | Date limite reportée – Consultation sur l’EPTC 2

Deadline Extended – TCPS 2: Proposed Revisions to Research Involving Human Cells and Cell Lines
________________________________

On October 2017, the Panel on Research Ethics launched a period of public comment on a set of proposed changes to the second edition of the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans – TCPS 2 (2014).

This set of changes pertains to research involving human cells and cell lines.

The deadline for receipt of comments has been extended to January 5, 2018. All comments received will be posted online unless the contributor requests that they remain confidential.

Feedback received will be taken into consideration when the Panel submits recommendations to the federal research Agencies (CIHR, NSERC and SSHRC) that are responsible for approving revisions to the Policy.

Date limite reportée – EPTC 2 : Révisions proposées concernant la recherche avec des cellules et des lignées cellulaires humaines
________________________________

Le 17 octobre 2017, le Groupe en éthique de la recherche (GER) a entamé une période de commentaires publics sur un ensemble de changements proposés à la deuxième édition de l’Énoncé de politique des trois Conseils : Éthique de la recherche avec des êtres humains – EPTC 2 (2014).

Cet ensemble de changements porte sur la recherche avec des cellules et des lignées cellulaires humaines.

La date limite pour la réception de commentaires a été reportée au 5 janvier 2018. Tous les commentaires reçus seront affichés en ligne, sauf les commentaires dont l’auteur demande qu’ils restent confidentiels.

Les commentaires reçus seront pris en considération lorsque le GER présentera des recommandations aux organismes de recherche fédéraux (CRSH, CRSNG et IRSC) qui ont à approuver les révisions à la Politique.

 

JOB POSTING: CRA (Research Asst/Tech 3) at BC Children’s Peds Hem/Onc/B

See a full job posting at: www.hr.ubc.ca/jobs/staff.php?job_id=27663

The incumbent is required to conduct all research activities in an ethical manner, suited to the proper activities of the University of British Columbia and to the professional organizations governing his or herself and those governing the activities of the institution and all other investigators. Any procedures or data recorded as part of a trial must be accurate and must accurately reflect the work performed. Strict confidentiality of all study participants must be adhered to. All activities involving participants are accountable to the Principal Investigator, the Department Head, and the candidate’s governing professional organization.

The Research Technician (RT3) will report directly to the Clinical Trials Unit Manager (CTU Manager) who is under the supervision of the Division head and Research Director, respectively. The incumbent will also report to and receive direction from the Principal Investigator of each assigned project.

The RT3 works with physicians and staff at BC Children’s Hospital in the Hem/Onc/BMT clinical research office with nine other CRAs. Coordination within the Hematology/Oncology/BMT Outpatient Clinic and Inpatient Ward, as well as outside physician offices is essential in order to complete study requirements and obtain the information for data submission. The RT3’s office is located in B315 of the Shaughnessy Building.

Qualifications:  Undergraduate degree in a relevant discipline or Graduation from a technical college or institute. Clinical research professional certification through the Society of Clinical Research Associates (SoCRA) or the Association of Clinical Research Professionals (ACRP), transportation of Dangerous Goods Certificate preferred. Transportation of Dangerous Goods Certificate preferred. Minimum of 3 years related experience or the equivalent combination of education and experience. Required: – knowledge of medical terminology and patient record systems – medium to high degree of computer literacy including familiarity with Microsoft Word, Access and Excel Assets: – demonstrated knowledge and experience with Pediatric oncology – familiarity with database management programs – knowledge of Good Clinical Practice. Attentive to detail, with the ability to work quickly and accurately Excellent organizational and interpersonal skills a must A high degree of motivation, enthusiasm and initiative Ability to effectively prioritize tasks and meet deadlines Ability to exercise initiative and maintain confidentiality Communicates effectively both orally and in writing Ability to learn new software Ability to work both independently and within a team environment. Physical ability to do the job

C17 Call for LOI: The 100% Fund Grant Competition and the C17Operating Grant Competition

C17 is pleased to announce the inaugural round of The 100% Fund C17 Grant Competition and Round 21 of the C17 Research Network Operating Grant Competition.

The C17 Operating Grant Competition is focused on multicenter, multidisciplinary pediatric oncology/hematology research.

The purpose of The 100% Fund Grant Competition is to target directly pediatric cancers that are rare and hard to treat—cancers that have not responded to available therapies. Applications addressing the cancer types below will be considered for the fall 2017 competition.

In recognition of its 30th anniversary, Childhood Cancer Canada established The 100% Fund to challenge the odds for children and teens who do not, yet, have their cure.

Please see the calls for LOI, LOI forms and C17 Award Guide linked below. The application form and guidance document also can be downloaded from the C17 website (www.c17.ca/council-and-administrators/research/) under Committees> Research Network. The submission deadline for C17 LOIs is December 14, 2017 at 4 PM MST.